インスリンデリバリーデバイスの世界市場（2022年～2028年）

世界のインスリンデリバリーデバイスの市場規模は、予測期間中にCAGRで8.8%の大幅な成長が予測されています。

当レポートでは、世界のインスリンデリバリーデバイス市場について調査分析し、市場概要、競合情勢、セグメント分析、地域分析などを提供しています。

目次

第1章 レポートサマリー

第2章 市場概要と考察

• 調査範囲
• アナリストの考察と現在の市場動向

第3章 競合情勢

• Novo Nordisk A/S
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の発展
• Eli Lilly and Co.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の発展
• Sanofi SA
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の発展
• Becton Dickinson, and Co.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の発展
• Medtronic PLC
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の発展
• 主要戦略分析
• 主要企業に対するCOVID-19の影響

第4章 市場セグメンテーション

• 世界のインスリンデリバリーデバイス市場：タイプ別
  • インスリン注射器
  • インスリンペン
  • インスリンジェット注射
  • インスリンポンプ
• 世界のインスリンデリバリーデバイス市場：エンドユーザー別
  • 病院・診療所
  • 在宅治療

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• その他の地域

第6章 企業プロファイル

• Abbott Laboratories, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Co.
• Bigfoot Biomedical Inc.
• Biocon Ltd.
• F. Hoffmann-La Roche AG
• Gerresheimer AG
• Insulet Corp.
• MannKind Corp.
• Medtronic PLC
• Sanofi SA
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Wockhardt Ltd.
• Ypsomed AG

LIST OF TABLES

• 1. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 2. GLOBALINSULIN SYRINGES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 3. GLOBALINSULIN PENSMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 4. GLOBALINSULIN JET INJECTORSMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 5. GLOBALINSULIN PUMPSMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 6. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 7. GLOBALINSULIN DELIVERY DEVICES IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 8. GLOBAL INSULIN DELIVERY DEVICES IN HOMECAREMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 9. GLOBAL INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 10. NORTH AMERICAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 11. NORTH AMERICAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 12. NORTH AMERICAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 13. EUROPEAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 14. EUROPEAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 15. EUROPEAN INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 16. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 17. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 18. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 19. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 20. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 21. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL INSULIN DELIVERY DEVICES MARKET, 2021-2028 ($ MILLION)
• 2. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
• 3. GLOBAL INSULIN SYRINGES MARKETSHAREBY REGION, 2021 VS 2028 (%)
• 4. GLOBALINSULIN PENSMARKET SHARE BY REGION, 2021 VS 2028 (%)
• 5. GLOBAL INSULIN JET INJECTORSMARKET SHARE BY REGION, 2021 VS 2028 (%)
• 6. GLOBAL INSULIN PUMPSMARKET SHARE BY REGION, 2021 VS 2028 (%)
• 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE BY END-USER, 2021 VS 2028 (%)
• 8. GLOBAL INSULIN DELIVERY DEVICES IN HOSPITALS AND CLINICSMARKET SHARE BY REGION, 2021 VS 2028 (%)
• 9. GLOBAL INSULIN DELIVERY DEVICES IN HOMECAREMARKET SHARE BY REGION, 2021 VS 2028 (%)
• 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE BY REGION, 2021 VS 2028 (%)
• 11. US INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 12. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 13. UK INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 14. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 15. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 16. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 17. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 18. REST OF EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 19. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 20. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 21. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 22. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 23. REST OF ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
• 24. REST OF THE WORLD INSULIN DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)

Global Insulin Delivery Devices Market Size, Share & Trends Analysis Report, By Type (Insulin Syringes, Insulin Pens, Insulin Jet Injectors, and Insulin Pumps), By End-User (Hospitals & Clinics and Homecare)Forecast Period (2022-2028)

The global insulin delivery devicesmarket is anticipated to grow at a substantial CAGR of 8.8% during the forecast period. Government support and reimbursement policies in some countries such as the US are positively driving the market growth. The federal government offers financial support to diabetes patients by providing them with various health insurance. Medicare, the Children's Health Insurance Program (CHIP), TRICARE, and veterans' healthcare programs are some programs that support patients. Moreover, some acts such as the Affordable Care Act (ACA) prevent insurers from denying coverage or charging higher premiums to people with preexisting conditions, such as diabetes are also fueling the market considerably. The features of insulin delivery devices including theiraccuracy, efficiency, and cost-effectiveness attract customers from different regions and thus drive market growth. For instance, in September 2020, Medtronic announced that it has secured approval from the US FDA for its MiniMed 770G hybrid closed loop system. Equipped with the company's highly advanced SmartGuard technology, this inventive insulin delivery solution can be connected to a smartphone and can be modulated for children as young as two years of age.

The global insulin delivery devices market is segmented based on type and end-user. Based on the end-user, the homecare usage segment held the major market share in 2021. Easy and convenient usage of these devices at home is anticipated to boost the segmental growth of the market during the forecast period. Based on type, the global insulin delivery devices market is segmented into insulin syringes, insulin pens, insulin jet injectors, and insulin pumps. Insulin pumps are anticipated to exhibit considerable growth during the forecast period owing to the introduction of advanced insulin devices such as portable insulin pumps. For instance, in September 2020, Insulet Corp. announced that its Omnipod DASH Insulin Management System will now be commercially available in Israel, Switzerland, Austria, Germany, Belgium, and France in the next few weeks. This product is already available in Denmark, Norway, Finland, and Sweden.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American segment is expected to hold a significant share in the global Insulin Delivery Devices market due to the rising diabetic population and the accessibility of technologically advanced devices are the factors contributing to the high market growth in the United States.According to IDF, in 2021 around 83 million people had diabetes in North America. 1 in 4 adults living with diabetes isundiagnosed. 931,000 deaths were caused by diabetes in 2021. $415 billion was spent on diabetes in 2021.

The major companies serving the global Insulin Delivery Devices market include Novo Nordisk A/S, Eli Lilly and Co., Sanofi SA, Becton, Dickinson, and Co., Medtronic PLC., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance,in June 2020, Tandem Diabetes Care and Abbott entered into a partnership to develop and commercialize integrated diabetes management solutions.These offerings will combine Abbott's industry-leading continuous glucose monitoring technology with Tandem's path-breaking insulin delivery systems to improve the management of blood sugar levels in diabetics.

Research Methodology

The market study of the global insulin delivery devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Insulin Delivery Devices Market Research and Analysis by Type

2. Global Insulin Delivery Devices Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the global insulin delivery devices market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global insulin delivery devices market.
• Insights about market determinants that are stimulating the global insulin delivery devices market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

Category- Medical Devices

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Insulin Delivery Devices Market
• Recovery Scenario of Global Insulin Delivery Devices Market
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Novo Nordisk A/S
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Eli Lilly and Co.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Sanofi SA
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Becton Dickinson, and Co.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Medtronic PLC
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Key Strategy Analysis
• 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

• 4.1. Global Insulin Delivery Devices Market by Type
  • 4.1.1. Insulin Syringes
  • 4.1.2. Insulin Pens
  • 4.1.3. Insulin Jet Injections
  • 4.1.4. Insulin Pumps
• 4.2. Global Insulin Delivery Devices Market by End-User
  • 4.2.1. Hospitals and clinics
  • 4.2.2. Homecare

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Abbott Laboratories, Inc.
• 6.2. B. Braun Melsungen AG
• 6.3. Becton, Dickinson and Co.
• 6.4. Bigfoot Biomedical Inc.
• 6.5. Biocon Ltd.
• 6.6. F. Hoffmann-La Roche AG
• 6.7. Gerresheimer AG
• 6.8. Insulet Corp.
• 6.9. MannKind Corp.
• 6.10. Medtronic PLC
• 6.11. Sanofi SA
• 6.12. Tandem Diabetes Care, Inc.
• 6.13. Valeritas Holdings, Inc.
• 6.14. Wockhardt Ltd.
• 6.15. Ypsomed AG